Improving Iron Status of Children: Potential of Amaranth

Sponsor
Wageningen University (Other)
Overall Status
Completed
CT.gov ID
NCT01224535
Collaborator
University of Nairobi (Other), Nestlé Foundation (Other), Nevin Scrimshaw International Nutrition Foundation (Other)
270
1
3
8
33.8

Study Details

Study Description

Brief Summary

Introduction: Iron deficiency anaemia remains a significant public health challenge. Localized food based approaches may offer a large opportunity to improve lives and address the widespread micronutrient deficiencies such as iron in affected households. Viable solutions where iron rich foods are not readily available may come through diversification approaches using foods such as amaranth grain reported to contain high iron content and good quality protein in conjunction with the use of in-home fortification.

Objectives: To determine the efficacy of maize porridge enriched with amaranth flour on improving diet quality, iron intake and status in children 12-59 months in a semiarid area in Kenya.

Study population: The study population will comprise children aged 12-59 months in Migwani, within the larger Mwingi district, Kenya. Mothers or principal caretakers will be interviewed on behalf of the children. In total, 270 children will be enrolled in the study.

Study design:

The study has a randomized controlled trial design conducted over a period of 4 months/16 weeks.

Treatment/hypothesis: All participating children will be required to take the provided porridge equivalent to 80g of flour 5 days a week for 16 weeks. There will be 3 treatments groups as follows; (1) maize porridge enriched with amaranth grain flour at 70:30 maize/amaranth ratio, (2) maize porridge fortified with a multiple micronutrient powder (MixMe™) and (3) plain maize porridge group. Hypothesis: there will be a significant difference in hemoglobin and iron status between the three groups.

Methods: Blood samples (5ml) will be collected by veni-puncture at baseline and after intervention. Hb concentration, Zinc protoporphyrin (ZnPP) and malaria infection will be assessed in the field. Analyses of serum ferritin, serum transferrin receptor and C-reactive protein (CRP) will be done at the participating laboratories.

Main study parameter/Endpoints: Change in Hb concentration is the primary outcome of this study. Body iron measured by serum ferritin (SF) and serum transferrin receptor (STfR) are the secondary outcome. Iron deficiency will be defined as SF concentration <12 µg/L and tissue iron deficiency will be defined as serum transferrin receptor concentration of

8.3mg/L. Infection will be assessed by raised CRP (>10mg/L) as an indicator of acute inflammation and presence of malaria.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Maize and Amaranth
N/A

Detailed Description

Background and Rationale The most severe problems of micronutrient deficiency are found amongst resource poor, food insecure and vulnerable households in developing countries. From the 1999 Kenya national survey on micronutrients, it was estimated that seven out of every ten children under five years are likely to be anaemic (Hb<110g/L) and nearly half (43.2%) were iron deficient.

The period of complementary feeding is a critical and vulnerable time in the growth and development of children. Poor complementary feeding practices combined with chronic food insecurity are found to substantially contribute to the widespread multiple micronutrients deficiencies in developing countries.

A recent food consumption study in Mwingi district in Kenya, showed that ugali (stiff maize porridge) was the primary complementary food. The use of ugali as the primary complementary food suggests that the children may be at risk of inadequate micronutrient intake among children 12-23 months. These findings underscore the need to establish solutions to increase dietary diversity and to promote use of foods that are rich in nutrients such as iron.

Amaranth grain offers the prospect of considerably improving dietary food diversification in semi arid areas. Agronomic investigations indicate that amaranth grain contains high iron concentrations ranging from 7.6-27 mg/100g of edible portion. Amaranth grain is a hardy crop and can withstand low rainfall. As such, grain amaranth may offer a viable solution in semi-arid areas where iron rich foods such as animal and fortified products are not readily available.

This study has therefore been designed to investigate the efficacy of porridge made from amaranth enriched maize flour in improving the diet quality and iron intake in children 12-59 months in a semi-arid area in Kenya. Home fortification of complementary foods using micronutrient powders has also been shown to reduce iron deficiency anaemia in many resource-poor settings including Kenya.

Objectives The primary objective of this study is To determine the efficacy of maize porridge enriched with amaranth grain flour on improving iron intake and status in children 12-59 months in a semi arid area in Kenya.

In addition we aim:
  • To determine the efficacy of amaranth grain enriched maize porridge compared to maize porridge fortified with micronutrient multi-mix powder (MixMe™) to improve iron status and intake of children 12-59 months.

  • To determine the iron, zinc and nutritional status of children 12-59 months.

Hypothesis

We hypothesize that:
  • Children receiving amaranth grain enriched maize porridge will show greater improvement in iron status than those receiving plain maize porridge.

  • Children receiving amaranth enriched maize porridge will show less improvement in iron status than those receiving maize porridge fortified with micronutrient multi-mix powder (MixMe™).

Study Area and Population The study will be conducted in Migwani within the larger Mwingi District in Eastern Kenya. This area falls within the arid and semi arid area (ASAL) and thus experiences food shortage for most part of the year. The study population will comprise children aged 12-59 months. Mothers or principal caretakers will be interviewed on behalf of the children.

Study Design The study will have a randomized controlled trial design conducted over a period of 4 months/16 weeks.

The administrative study area has been purposively selected as it falls within an agro-ecological zone of a semi-arid area. Random sampling out of a total of six Sub-locations in Migwani will be done to get 4 Sub-locations. Within a Sub-location, individual sampling units (Household with a child aged 12-59 months) will be selected using a random walk method until the required sample size of 68 children is achieved per Sub-location. Children who meet the inclusion criteria shall be randomly assigned to one of the following treatment groups:

  1. Maize porridge enriched with amaranth grain flour

  2. Maize porridge fortified with a multiple micronutrient powder (MixMe™)

  3. Plain maize porridge

Study Design

Study Type:
Interventional
Anticipated Enrollment :
270 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Improving Iron Status of Children in a Semi-arid Area of Kenya: the Potential of Amaranth Grain Flour
Study Start Date :
Oct 1, 2010
Actual Primary Completion Date :
Jun 1, 2011
Actual Study Completion Date :
Jun 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Maize porridge with Amaranth

Maize porridge enriched with amaranth grain flour at 70:30 maize/amaranth ratio (80g/day)

Dietary Supplement: Maize and Amaranth
80g porridge per day, 5 days a week, for 16 weeks (4 months)
Other Names:
  • Mix Me micro-nutrient powder
  • Active Comparator: Maize flour with multiple micronutrients

    Maize porridge fortified with a multiple micronutrient powder (MixMe™)

    Dietary Supplement: Maize and Amaranth
    80g porridge per day, 5 days a week, for 16 weeks (4 months)
    Other Names:
  • Mix Me micro-nutrient powder
  • Placebo Comparator: Maize Porridge

    Plain maize porridge group

    Dietary Supplement: Maize and Amaranth
    80g porridge per day, 5 days a week, for 16 weeks (4 months)
    Other Names:
  • Mix Me micro-nutrient powder
  • Outcome Measures

    Primary Outcome Measures

    1. Hemoglobin [Start of study (T=0), End of study (T=4months)]

      Hemoglobin (g/l)

    Secondary Outcome Measures

    1. Iron Status [Begin (t=0), End of study (t=4 months)]

      Serum Ferritin microgram/l), serum Transferrin Receptor (mg/l)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Months to 59 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Aged 12-59 months at the time of entry into the study

    • Resident in village for at least 6-months and the caretaker plans to remain in the area for the next year

    • Apparently healthy at the time of entry into the study

    Exclusion Criteria:
    • Severe anaemia i.e. Hb concentration <70 g/L (See section 5.5)

    • Taking iron containing haematinic supplements

    • Transfused in the last six months

    • Severely undernourished i.e. anthropometric indices <-3 Z score

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Migwani Area Migwani Area Mwingi District Kenya

    Sponsors and Collaborators

    • Wageningen University
    • University of Nairobi
    • Nestlé Foundation
    • Nevin Scrimshaw International Nutrition Foundation

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Wageningen University
    ClinicalTrials.gov Identifier:
    NCT01224535
    Other Study ID Numbers:
    • Amaranth
    • 10/15
    First Posted:
    Oct 20, 2010
    Last Update Posted:
    Sep 29, 2011
    Last Verified:
    Oct 1, 2010

    Study Results

    No Results Posted as of Sep 29, 2011